High Flow Nasal Cannula vs Low Flow Oxygen Therapy in Bronchiolitis

NCT ID: NCT03015051

Last Updated: 2020-09-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-31

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Bronchiolitis is the most common respiratory infection of the lower respiratory tract that affects 11-12% of infants in their first year of life. Approximately 1-2% of patients with bronchiolitis require hospital admission because of poor feeding and/or breathing difficulties. The standard treatment for bronchiolitis is represented by oxygen-therapy and hydration while neither steroids nor epinephrine nor bronchodilators are recommended. One of the techniques of administration of oxygen in bronchiolitis is represented by the high flow (HFNC) or by a system in which oxygen is delivered to 2L/kg through nasal cannulas. The HFNC provides humidification, heating and oxygen, ensuring a minimum positive pressure, reduces breathing load and allows for better nutrition. The main aim of therapy with high flows is to reduce the days of oxygen therapy and the cases of intubation. However, up to now, there have been few studies on the use of HFNC in Pediatric Emergency Units. The Cochrane review on this topic, updated in May 2013, included only one randomized controlled trial (RCT) on a pilot study of 19 subjects comparing HFNC with oxygen administered via "head box". The oxygen saturation was higher in children HFNC after 8 (00% versus 96%, p=0.04) and 12 hours (99% vs 96%, p=0.04) but similar in both groups at 24 hours. The authors concluded that the available evidence is insufficient to determine the effectiveness of HFNC.

The aim of this study is to evaluate in a large number of cases the effectiveness of treatment with high flow versus standard treatment, in children with bronchiolitis referred to a Pediatric Emergency Department.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bronchiolitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High flow

High flow (2 L/kg/min) nasal cannula oxygen therapy

Group Type EXPERIMENTAL

Oxygen

Intervention Type DRUG

Low flow

Low flow (max 3 L/min) oxygen therapy

Group Type ACTIVE_COMPARATOR

Oxygen

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oxygen

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosis of bronchiolitis
* age \>28 days and \<6 months
* Oxygen saturation (SaO2) \<92%
* respiratory rate \>60 breaths/min
* dyspnea with respiratory distress assessment instrument (RDAI) score ≥8
* daily milk or food intake less than 2/3 than normally assumed

Exclusion Criteria

* chronic diseases or syndromes
* respiratory diseases (i.e. bronchopulmonary dysplasia)
* heart diseases
* preterm birth (before 36 weeks of gestational age)
Maximum Eligible Age

6 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

IRCCS Burlo Garofolo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Luca Ronfani

Head of Clinical Epidemiology and Public Health Research Unit

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Egidio Barbi, MD

Role: STUDY_CHAIR

IRCCS Burlo Garofolo, Trieste, Italy

Stefania Norbedo, MD

Role: STUDY_DIRECTOR

IRCCS Burlo Garofolo, Trieste, Italy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ospedale Maggiore

Bologna, Emilia-Romagna, Italy

Site Status

Ospedale Morgagni-Pierantoni

Forlì, Emilia-Romagna, Italy

Site Status

Ospedale Ravenna AUSL Romagna

Ravenna, Emilia-Romagna, Italy

Site Status

Ospedale Santa Maria degli Angeli

Pordenone, Friuli Venezia Giulia, Italy

Site Status

Pediatric Emergency Department, IRCCS Burlo Garofolo

Trieste, Friuli Venezia Giulia, Italy

Site Status

Ospedale Pediatrico IRCCS Bambino Gesú

Rome, Lazio, Italy

Site Status

Istituto G. Gaslini

Genoa, Liguria, Italy

Site Status

Fondazione MBBM c/o Ospedale San Gerardo

Monza, Lombardy, Italy

Site Status

Ospedale A. Cardarelli

Campobasso, Molise, Italy

Site Status

Ospedale Infantile Regina Margherita

Turin, Piedmont, Italy

Site Status

Ospedale Castelli

Verbania, Piedmont, Italy

Site Status

Ospedale Giovanni Paolo II

Olbia, Sardinia, Italy

Site Status

Ospedale Provinciale di Macerata

Macerata, The Marches, Italy

Site Status

Ospedale Principe di Piemonte Area Vasta 2

Senigallia, The Marches, Italy

Site Status

Azienda Ospedaliera di Padova

Padua, Veneto, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

High flow RCT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Using HFNC in Bronchiolitis
NCT03342781 COMPLETED NA
High Flow Nasal Cannula Rates in Pediatric Asthma
NCT06379607 ENROLLING_BY_INVITATION NA